BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31004651)

  • 21. Mouse double minute 2 amplification in oesophageal squamous cell carcinoma is associated with better outcome.
    Jiang D; Chen L; Huang J; Wang H; Song Q; Shi P; Wang H; Hou Y
    Histopathology; 2020 Dec; 77(6):963-973. PubMed ID: 32652667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copy number loss of variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma.
    Wu Y; Liu X; Hu L; Tao H; Guan X; Zhang K; Bai Y; Yang K
    Int J Clin Exp Pathol; 2015; 8(11):14479-85. PubMed ID: 26823766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatment.
    Ikeguchi M; Ueda T; Fukuda K; Yamaguchi K; Tsujitani S; Kaibara N
    Am J Clin Oncol; 2002 Oct; 25(5):454-9. PubMed ID: 12393983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.
    Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY
    Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis.
    Wang J; Luo FF; Huang TJ; Mei Y; Peng LX; Qian CN; Huang BJ
    Aging (Albany NY); 2021 Sep; 13(17):21758-21777. PubMed ID: 34520390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
    Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
    Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.
    Li J; Tang Y; Huang L; Yu Q; Hu G; Yuan X
    PLoS One; 2016; 11(7):e0158613. PubMed ID: 27414035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of increased p53 expression in the decrease of mitochondrial DNA copy number and increase of SUV
    Lin CS; Huang YY; Pan SC; Cheng CT; Liu CC; Shih CH; Ho HL; Yeh YC; Chou TY; Lee MY; Wei YH
    Mitochondrion; 2019 Jul; 47():54-63. PubMed ID: 31071450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.
    Oshima K; Kato K; Ito Y; Daiko H; Nozaki I; Nakagawa S; Shibuya Y; Kojima T; Toh Y; Okada M; Hironaka S; Akiyama Y; Komatsu Y; Maejima K; Nakagawa H; Onuki R; Nagai M; Kato M; Kanato K; Kuchiba A; Nakamura K; Kitagawa Y
    Cancer Sci; 2022 Mar; 113(3):1018-1027. PubMed ID: 34962019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 gene amplification in esophageal carcinoma.
    Michalk M; Meinrath J; Künstlinger H; Koitzsch U; Drebber U; Merkelbach-Bruse S; Bollschweiler E; Kloth M; Hartmann W; Hölscher A; Quaas A; Grimminger PP; Odenthal M
    Oncol Rep; 2016 Apr; 35(4):2223-7. PubMed ID: 26796597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma.
    Baba Y; Watanabe M; Murata A; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Sakamaki K; Nakao M; Baba H
    Clin Cancer Res; 2014 Mar; 20(5):1114-24. PubMed ID: 24423610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
    BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status.
    Arora S; Mathew R; Mathur M; Chattopadhayay TK; Ralhan R
    Pathol Oncol Res; 2001; 7(3):203-8. PubMed ID: 11692147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
    Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
    Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
    Luo HS; Wu DH
    Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma.
    Guo W; Zhang F; Shao F; Wang P; Li Z; Yang X; He Z; Shi S; Gao Y; He J
    Hum Pathol; 2019 Feb; 84():291-298. PubMed ID: 30296523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell culture in esophageal squamous cell carcinoma and the association with molecular markers.
    Shimada Y; Maeda M; Watanabe G; Yamasaki S; Komoto I; Kaganoi J; Kan T; Hashimoto Y; Imoto I; Inazawa J; Imamura M
    Clin Cancer Res; 2003 Jan; 9(1):243-9. PubMed ID: 12538476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
    Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
    Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.